| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
397,501 | 81,391 | 33,279 | 14,017 | 15,920 |
|
Cost of Revenue
|
-8,151 | -4,843 | -23,791 | 0 | -- |
|
Gross Profit
|
389,350 | 76,548 | 9,488 | 14,017 | -- |
| Selling, General and Administrative Expenses
|
-52,161 | -52,897 | -54,216 | -47,293 | -46,550 |
|
Research and Development Expenses
|
-153,160 | -129,619 | -119,484 | -103,785 | -85,725 |
|
Operating Income/Expenses
|
-205,321 | -182,516 | -173,700 | -151,078 | -132,275 |
|
Total Operating Profit/Loss
|
184,029 | -105,968 | -164,212 | -137,061 | -116,355 |
| Total Net Finance Income/Expense
|
-11,143 | -10,379 | -9,127 | -10,973 | -4,169 |
| Net Investment Income
|
-91,593 | 2,146 | -2,886 | 9,300 | -9,091 |
| Irregular Income/Expenses
|
0 | 0 | 28,434 | 54,208 | 0 |
|
Other Income/Expense, Non-Operating
|
0 | -- | 0 | 499 | -- |
|
Non-Operating Income/Expenses, Total
|
-102,736 | -8,233 | 16,421 | 53,034 | -13,260 |
|
Pretax Income
|
81,293 | -114,201 | -147,791 | -84,027 | -129,615 |
|
Net Income from Continuing Operations
|
78,931 | -114,201 | -147,791 | -84,027 | -129,615 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
78,931 | -114,201 | -147,791 | -84,027 | -129,615 |
|
Non-Controlling/Minority Interests
|
51 | -- | -- | -- | -- |
|
Net Income after Non-Controlling/Minority Interests
|
78,982 | -114,201 | -147,791 | -84,027 | -129,615 |
|
Net Income Available to Common Stockholders
|
78,982 | -114,201 | -147,791 | -84,027 | -129,615 |
|
Diluted Net Income Available to Common Stockholders
|
78,982 | -114,201 | -147,791 | -84,027 | -129,615 |
| Basic EPS
|
0.89 | -1.42 | -2.12 | -1.49 | -2.87 |
| Diluted EPS
|
0.87 | -1.42 | -2.12 | -1.49 | -2.87 |
|
Basic Weighted Average Shares Outstanding
|
83,717.39 | 80,430.19 | 69,822.35 | 56,486.53 | 45,177.86 |
|
Diluted Weighted Average Shares Outstanding
|
84,581.06 | 80,430.19 | 69,822.35 | 56,486.53 | 45,177.86 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
92,436 | -103,822 | -138,664 | -73,054 | -125,446 |
|
EBITDA
|
104,602 | -91,216 | -125,983 | -59,330 | -116,843 |
|
Normalized EBITDA
|
138,580 | -70,902 | -126,340 | -93,973 | -79,129 |
|
Normalized Income
|
112,909 | -93,887 | -148,148 | -118,670 | -91,901 |
|
Total Unusual Items
|
33,978 | 20,314 | -357 | -34,643 | 37,714 |
|
Total Unusual Items Excluding Goodwill
|
33,978 | 20,314 | -357 | -34,643 | 37,714 |
12/31/2022 - 6/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade